Evidence of Oxytosis/Ferroptosis in Niemann–Pick Disease Type C
International Journal of Molecular Sciences · 23.03.2025 · 26 (7) · 2915
DOI: 10.3390/ijms26072915 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Molecular Sciences, online erschienen am 23.03.2025. Verfasst von Kayla L Sanchez und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pathology and Human Anatomy, School of Medicine, Loma Linda University, Loma Linda, CA 92354, USA. Hauptthemen laut MEDLINE: Niemann-Pick Disease, Type C, Ferroptosis. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 36 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIH HHS, NIA NIH HHS, NIGMS NIH HHS.
Abstract (Originalsprache)
Niemann–Pick Disease Type C (NPC) is a hereditary neurodegenerative disease characterized by selective cell vulnerability, particularly affecting cerebellar anterior Purkinje neurons. These neurons exhibit a distinctive pattern of degeneration due to the loss of NPC1 and/or NPC2 protein function, progressively extending towards posterior cerebellar regions. Our study aimed to explore the early factors influencing this selective vulnerability of anterior Purkinje neurons in NPC. Oxytosis/ferroptosis, a novel form of regulated cell death, has been implicated in neurodegenerative diseases, with its inhibition showing promising therapeutic potential. Our laboratory has previously identified parallels between NPC cellular pathology and ferroptotic markers, including elevated levels of lipid peroxidation and iron, mitochondrial dysfunction, and Ca2+ dyshomeostasis. However, whether oxytosis/ferroptosis underlies NPC cellular pathology remains unexplored. We hypothesize that loss of NPC1 function increases vulnerability to ferroptosis and that anti-ferroptotic compounds will reverse NPC cellular pathology. Through bioinformatic analyses of pre-symptomatic Npc1−/− Purkinje neurons and in vitro studies using primary dermal fibroblasts derived from NPC patients, we provide evidence suggesting that oxytosis/ferroptosis may play a pathogenic role in NPC. These findings highlight the potential of anti-ferroptotic compounds as a promising therapeutic strategy to mitigate neurodegeneration in NPC and potentially other related disorders.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pathology and Human Anatomy, School of Medicine, Loma Linda University, Loma Linda, CA 92354, USA.
- The Salk Institute for Biological Studies, 10010 North Torrey Pines Road, La Jolla, CA 92037, USA.
ORCID-Profile: Kayla L Sanchez, Andrew Tolan, Douglas W Anderson, Alexandra N Shin, Samuel D Shin, Antonio Currais, David Soriano-Castell, Pamela Maher, Salvador Soriano
Förderung
- NIH HHS
- NIA NIH HHS
- NIGMS NIH HHS
- National Institutes of Health
- Bundy Foundation
Zitieren
APA
Sanchez, K. L., Kim, J., White, J. B., Tolan, A., Rajagopal, N. P., Anderson, D. W., Shin, A. N., Shin, S. D., Currais, A., Soriano-Castell, D., Maher, P., & Soriano, S. (2025). Evidence of Oxytosis/Ferroptosis in Niemann–Pick Disease Type C. International Journal of Molecular Sciences, 26(7), 2915. https://doi.org/10.3390/ijms26072915
Vancouver
Sanchez KL, Kim J, White JB, Tolan A, Rajagopal NP, Anderson DW, et al. Evidence of Oxytosis/Ferroptosis in Niemann–Pick Disease Type C. International Journal of Molecular Sciences. 2025;26(7):2915. doi:10.3390/ijms26072915
BibTeX
@article{Sanchez2025,
author = {Sanchez, Kayla L and Kim, Jeanyoung and White, Jacob B and Tolan, Andrew and Rajagopal, Naren P and Anderson, Douglas W and Shin, Alexandra N and Shin, Samuel D and Currais, Antonio and Soriano-Castell, David and Maher, Pamela and Soriano, Salvador},
title = {Evidence of Oxytosis/Ferroptosis in Niemann–Pick Disease Type C},
journal = {International Journal of Molecular Sciences},
year = {2025},
volume = {26},
number = {7},
pages = {2915},
doi = {10.3390/ijms26072915}
}
EUVIMED